Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sarcoma, Synovial × Dehydroepiandrosterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Sarcoma, Synovial 1 Breast Neoplasms, Male 1

Interventions

Cyclophosphamide 9 fludarabine 5 tazemetostat 2 sargramostim 2 pembrolizumab 2 fludarabine phosphate 2 Doxorubicin 2 ribociclib 1 poly ICLC 1 pegfilgrastim 1 itacitinib 1 cixutumumab 1 baricitinib 1 aldesleukin 1 Rifampin 1 Radiotherapy 1 Radiation 1 Itraconazole 1 Immunotherapy, Adoptive 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 INCB039110 1 Filgrastim 1 Dehydroepiandrosterone 1 Decitabine 1 Chemotherapy, Adjuvant 1 Celecoxib 1 CLR1404 1 Adjuvants, Pharmaceutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02683148 2019-09-09

DHEA in Synovial Sarcoma Patients

Washington University School of Medicine

Phase 1 Terminated

Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡